Publications by authors named "Marion Tonneau"

Claim this Profile
Q
Quality assurance of contouring and dosimetric consistency in the GETUG-AFU 31 salvage prostate stereotactic reirradiation trial.
Marion Tonneau, Clarisse Bartau, Thomas Lacornerie, Meryem Brihoum, David Pasquier

Radiother Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for lung metastases.
Antonin Levy, Marion Tonneau, Julien Darréon, Jonathan Khalifa, Delphine Antoni

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation and Prospective Deployment of an Automated Deep Learning-Based Coronary Segmentation and Cardiac Toxicity Risk Prediction System.
Christian V Guthier, Christopher E Kehayias, Cosmin Ciausu, Jordan O Gasho, John He, Marion Tonneau

ArXiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005.
Stephanie Alley, Marion Tonneau, Damien Olivié, Clare M Tempany-Afdhal, Peter L Choyke

J Magn Reson Imaging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine testing after radiotherapy of brain or head and neck tumors, a snapshot on current practice.
Marion Tonneau, Jordan Bouter, Shakeel Sumodhee, Valerie Bernier, Juliette Thariat

Bull Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients.
Abdou Khadir Dia, Alona Kolnohuz, Sevinj Yolchuyeva, Marion Tonneau, Fabien Lamaze

J Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting early stage lung cancer recurrence and survival from combined tumor motion amplitude and radiomics on free-breathing 4D-CT.
Emilie Ouraou, Marion Tonneau, William T Le, Edith Filion, Marie-Pierre Campeau

Med Phys· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.
Fatemeh Vahidian, Fabien C Lamaze, Cédrik Bouffard, François Coulombe, Andréanne Gagné, Marion Tonneau

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Cecilia Hes, Antoine Desilets, Marion Tonneau, Omar El Ouarzadi, Marina De Figueiredo Sousa

Oral Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.
Sevinj Yolchuyeva, Leyla Ebrahimpour, Marion Tonneau, Fabien Lamaze, Michele Orain

J Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study.
Abdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, Marion Tonneau, Fabien C Lamaze

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy.
Francis Proulx-Rocray, Bertrand Routy, Rami Nassabein, Wiam Belkaid, Danh Tran-Thanh, Marion Tonneau

Cancer Treat Res Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study.
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, Fabien Lamaze, Michele Orain

JTO Clin Res Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Marion Tonneau, Corentin Richard, Bertrand Routy, Marie-Pierre Campeau, Toni Vu

Radiother Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study.
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, Fabien Lamaze, Michele Orain

Sci Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
Marion Tonneau, Kim Phan, Venkata S K Manem, Cecile Low-Kam, Francis Dutil

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, Leyla Ebrahimpour, Fabien C Lamaze

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Edouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, Francesca Parisi, Teresa Gorria, Marion Tonneau

Lung Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments.
Thomas Paz Del Socorro, Marion Tonneau, David Pasquier, Mathias Chamaillard

Cancer J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, Edouard Auclin, Justin Panasci

Oncoimmunology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.
Trisha M Wise-Draper, Houda Bahig, Marion Tonneau, Vidhya Karivedu, Barbara Burtness

Am Soc Clin Oncol Educ Book· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC).
Houda Bahig, Marion Tonneau, Normand Blais, Philip Wong, Edith Filion

Clin Transl Radiat Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review.
Marion Tonneau, Raphaëlle Mouttet-Audouard, Florence Le Tinier, Xavier Mirabel, David Pasquier

BMC Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review.
Marion Tonneau, Arielle Elkrief, David Pasquier, Thomas Paz Del Socorro, Mathias Chamaillard

Radiother Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis